- Home
- HLMN vs EWTX Comparison
HLMN vs EWTX Comparison
Compare HLMN & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLMN
- EWTX
- Stock Information
- Founded
- HLMN 1964
- EWTX 2017
- Country
- HLMN United States
- EWTX United States
- Employees
- HLMN N/A
- EWTX N/A
- Industry
- HLMN Industrial Machinery/Components
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- HLMN Consumer Discretionary
- EWTX Health Care
- Exchange
- HLMN Nasdaq
- EWTX Nasdaq
- Market Cap
- HLMN 1.8B
- EWTX 1.6B
- IPO Year
- HLMN N/A
- EWTX 2021
- Fundamental
- Price
- HLMN $9.45
- EWTX $15.70
- Analyst Decision
- HLMN Buy
- EWTX Buy
- Analyst Count
- HLMN 6
- EWTX 10
- Target Price
- HLMN $12.20
- EWTX $37.90
- AVG Volume (30 Days)
- HLMN 859.0K
- EWTX 957.0K
- Earning Date
- HLMN 11-04-2025
- EWTX 11-06-2025
- Dividend Yield
- HLMN N/A
- EWTX N/A
- EPS Growth
- HLMN 258.10
- EWTX N/A
- EPS
- HLMN 0.11
- EWTX N/A
- Revenue
- HLMN $1,505,004,000.00
- EWTX N/A
- Revenue This Year
- HLMN $8.04
- EWTX N/A
- Revenue Next Year
- HLMN $7.86
- EWTX N/A
- P/E Ratio
- HLMN $84.04
- EWTX N/A
- Revenue Growth
- HLMN 1.93
- EWTX N/A
- 52 Week Low
- HLMN $6.55
- EWTX $10.60
- 52 Week High
- HLMN $12.08
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- HLMN 46.47
- EWTX 51.91
- Support Level
- HLMN $8.98
- EWTX $14.94
- Resistance Level
- HLMN $9.31
- EWTX $15.84
- Average True Range (ATR)
- HLMN 0.22
- EWTX 0.98
- MACD
- HLMN -0.01
- EWTX -0.06
- Stochastic Oscillator
- HLMN 32.83
- EWTX 42.70
About HLMN Hillman Solutions Corp.
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.